Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.59    -0.31 (-10.69%)
Bid:
2.60
Ask:
2.91
Spread: 0.31 (11.923%)
Market Cap: £4.73m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

AGM Statement

20 Dec 2022 07:00

RNS Number : 2229K
Nanoco Group PLC
20 December 2022
 

20 December 2022

NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

 

AGM Statement

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, will hold its Annual General Meeting ("AGM") later this morning. Details of the arrangements were included in the Notice of Meeting issued on 4 November 2022.

The Company will make the following statement in respect of the first four months of the financial year ending 31 July 2023 ("the Period").

 

Operational and trading update

Financial performance in the Period has been comfortably in line with the Board's expectations. We continue to deliver R&D services under a number of contracted development programmes with different customers in the sensing market and are seeing an increase in demand for volumes of development materials.

We have a high level of confidence that we will receive sensing-application production orders in calendar year 2023, based on our visibility of customer final validation plans. As noted in our Preliminary Results, engagement from customers interested in our CFQD® materials for display applications also continues to grow.

Nanoco's organic business remains underpinned by the enhanced and extended funding put in place following the significantly over-subscribed fundraise in June 2022.

Samsung Litigation Update

As announced on 9 December 2022, the Group now has a firm date of 6 January 2023 for the start of its trial against Samsung in the Eastern District of Texas. The trial is expected to last one working week at the end of which the jury will deliver a verdict on whether Samsung has infringed Nanoco's IP, on whether any infringement was deliberate ('wilful'), the value of any damages award for sales of infringing units up to the date of the trial, and if a future 'running' royalty should also be awarded.

 

In November, Samsung submitted its appeals against the findings of the Patent Trial and Appeal Board which rejected all of Samsung's challenges against Nanoco's five patents and all 47 associated claims in the case. A final outcome to the PTAB appeals is expected in Q3 of CY23.

 

The Board looks forward to the opportunity to put our case to the court in Texas in January 2023, as well as progressing the law suits that Nanoco recently filed in Germany and China.

 

In summary, the Board remains confident that both the organic business and the litigation are sources of potentially significant shareholder value that will be transformative for the Group's prospects.

 

- Ends -

 

For further information, please contact:

Nanoco Group PLC:

Brian Tenner, CEO +44 (0)1928 761 404

Liam Gray, CFO & Company Secretary

 

Peel Hunt (Joint Corporate Broker):

Paul Gillam +44 (0) 20 7418 8900

James Smith

 

Turner Pope Investments (Joint Corporate Broker):

Andrew Thacker +44 (0) 20 3657 0050

James Pope

 

MHP: +44 (0) 203 128 8100

Reg Hoare

Pete Lambie

nanoco@mhpgroup.com

 

FORWARD LOOKING STATEMENTS

This announcement (including information incorporated by reference in this announcement) and other information published by Nanoco may contain statements about Nanoco that are or may be deemed to be forward looking statements. Such statements are prospective in nature. All statements other than historical statements of facts may be forward looking statements. Without limitation, statements containing the words "targets", "plans", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "projects" or "considers" or other similar words may be forward looking statements.

Forward looking statements inherently contain risks and uncertainties as they relate to events or circumstances in the future. Important factors such as business or economic cycles, the terms and conditions of Nanoco's financing arrangements, tax rates, or increased competition may cause Nanoco's actual financial results, performance or achievements to differ materially from any forward looking statements. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward looking statements, which speak only as of the date hereof. Nanoco disclaims any obligation to update any forward looking or other statements contained herein, except as required by applicable law.

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots and other nano-materials. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display, Sensor and Electronics markets. An interesting property of quantum dots is their absorption spectrum. Nanoco's HEATWAVE™ quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectrum, rendering them useful for applications including image sensors. Another interesting property of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco was founded in 2001 and is headquartered in Runcorn, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

visit: www.nanocotechnologies.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMEAKANFLEAFFA
Date   Source Headline
13th Aug 201311:45 amRNSHolding(s) in Company
5th Aug 20136:09 pmRNSTotal Voting Rights
5th Aug 20131:19 pmRNSHolding(s) in Company
26th Jul 20135:14 pmRNSDirector's Dealings
9th Jul 20131:58 pmRNSHolding(s) in Company
25th Jun 20133:30 pmRNSHolding(s) in Company
17th Jun 20137:00 amRNSHolding(s) in Company
12th Jun 20137:00 amRNSBlocklisting Interim Review
31st May 20132:43 pmRNSHolding(s) in Company
31st May 20139:22 amRNSHolding(s) in Company
15th May 20134:45 pmRNSHolding(s) in Company
14th May 20135:52 pmRNSHolding(s) in Company
9th May 201312:30 pmRNSRelocation of CEO to the US and Director Dealings
2nd May 20137:00 amRNSSigns Follow-on Agreement
29th Apr 20137:00 amRNSBoard Changes
24th Apr 20137:00 amRNSHolding(s) in Company
11th Apr 20134:46 pmRNSHolding(s) in Company
11th Apr 20137:00 amRNSHolding(s) in Company
28th Mar 20132:00 pmRNSAppointment of Joint Broker
27th Mar 20132:20 pmRNSHolding (s) in Company
18th Mar 20137:00 amRNSInterim Results
15th Feb 20132:08 pmRNSHolding(s) in Company
14th Feb 20131:00 pmRNSHolding(s) in Company
12th Feb 20139:49 amRNSHolding(s) in Company
6th Feb 20137:00 amRNSAppointment of Key Business Development Executives
29th Jan 20134:18 pmRNSHolding(s) in Company
28th Jan 20136:06 pmRNSHolding(s) in Company
24th Jan 20135:51 pmRNSHolding(s) in Company
23rd Jan 20137:00 amRNSLicensing Agreement with Dow Chemical
21st Jan 20137:00 amRNSNotification of Interim Results
11th Jan 20138:59 amRNSHolding(s) in Company
10th Jan 20131:19 pmRNSHolding(s) in Company
20th Dec 20127:00 amRNSSigns further agreement with Tokyo Electron
14th Dec 201210:25 amRNSResult of AGM
14th Dec 20127:00 amRNSAGM Statement
12th Dec 20123:37 pmRNSBlock Listing Application
4th Dec 20127:00 amRNSExercise of Options
12th Nov 20127:00 amRNSPosting of Annual Report & Accounts
23rd Oct 20127:00 amRNSGrant of Options
19th Oct 201212:43 pmRNSDirectors' Dealings and Exercise of Options
15th Oct 20127:00 amRNSPreliminary Results
5th Oct 20127:00 amRNSFollow-on Lighting Agreement
5th Sep 20127:00 amRNSNotification of Preliminary Results
20th Aug 20127:00 amRNSWins Government Grants
1st Aug 20127:00 amRNSTotal Voting Rights
31st Jul 20127:00 amRNSSigns Joint Development Agreement
27th Jul 20127:00 amRNSExercise of Options
25th Jun 20127:00 amRNSChange of Adviser
9th May 20127:00 amRNSAchieves US$2m Milestone
2nd Apr 20122:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.